Express Pharma

BASF to increase production capacity for tBa plant in China

0 156

Strengthens BASF’s global leading position in tertiary butylamine

BASF will expand the production capacity of its existing world-scale production plant for tertiary Butylamine (tBA) at the Nanjing Chemical Industry Park in China. tBA is a primary aliphatic amine that is used in the pharmaceutical and agricultural industries as a building block as well as an intermediate for the production of accelerators for the rubber and tire industry.

According to a company release, the company plans to increase the existing production capacity from 10,000 tonne to 16,000 tonne per year. The expansion is expected to come on stream in early 2015, subject to regulatory approval.

“The expansion will enable us to continue meeting the notably increased demand of our customers in Asia especially China reliably out of our local assets in China. We are proud to support the growth of our customers as their reliable local supplier with our commitment in product stewardship and high safety standards,” said Guido Voit, Senior Vice President, BASF Intermediates Asia Pacific.

EP News BureauMumbai


BASF appoints Sanjeev Gandhi to the Board of Executive Directors

20141130ep16
Sanjeev Gandhi

The Supervisory Board of BASF has appointed Sanjeev Gandhi to the Board of Executive Directors effective December 1, 2014. He has been head of BASF’s Intermediates division since 2010. After 12 successful years on the Board of Executive Directors, Dr Andreas Kreimeyer will retire with the expiration of his contract following the Annual Shareholders’ Meeting on April 30, 2015.

- Advertisement -

Leave A Reply

Your email address will not be published.